Recombinant Human HLA-DRA Protein

重组人HLA-DRA蛋白. | 重组人HLA-DRA蛋白. | 重组人类 HLA-DRA 蛋白

Major Histocompatibility Complex | Class II | DR Alpha | HLA-DRA1 | MHC Class II AntigenDRA | MLRW | Histocompatibility Antigen HLA-DR Alpha | HLAClass II Histocompatibility Antigen | DR Alpha Chain | MHC Cell Surface Glycoprotein | HLA-DRA | MHC class II

rp170117-1mg

1mg

无载体

≥90%(SDS-PAGE)

>90% (SDS-PAGE)

主要组织相容性复合体II类DR α人重组蛋白 Purity: >90%, by SDS-PAGE visualized with Coomassie® Blue Staining. Description: Major histocompatibility complex, class II, DR alpha (HLA-DRA) belongs to the MHC class II family. HLA-DRA binds peptides derived from antigens which access the endocytic route of antigen presenting cells (APC) and presents them on the cell surface for identification by the CD4 T-cells. The peptide binding cleft accommodates peptides of 10-30 residues. The peptides presented by MHC class II molecules are generated mainly by degradation of proteins which access the endocytic route, where they are processed by lysosomal proteases and other hydrolases.

重组表达

24.1 kDa

N-His

26.4kDa, reducing conditions; 26.4kDa, non-reducing condition

E. coli Accession #: P01903 | E. coli

人(Human)

26-216 aa

MGSSHHHHHHSSGLVPRGSIKEEHVIIQAEFYLNPDQSGEFMFDFDGDEIFHVDMAKKETVWRLEEFGRFASFEAQGALANIAVDKANLEIMTKRSNYTPITNVPPEVTVLTNSPVELREPNVLICFIDKFTPPVVNVTWLRNGKPVTTGVSETVFLPREDHLFRKFHYLPFLPSTEDVYDCRVEHWGLDEPLLKHWEFDAPSPLPETTE

No

Yes